PHASE I/II TRIAL OF PERIOPERATIVE OXALIPLATIN (O), CAPECITABINE (C) AND IRINOTECAN (I) FOR PATIENTS (PTS) WITH LOCALLY ADVANCED GASTRIC CANCER

被引：0
|
作者：
Utelbayeva, A. [1 ]
Arzykulov, Z. [1 ]
Izhanov, E. [1 ]
机构：
[1] Kazakh Sci Res Inst Oncol & Radiol, Alma Ata, Kazakhstan
来源：
ANNALS OF ONCOLOGY | 2010年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：45 / 46
页数：2
相关论文
共 50 条
  • [41] Encouraging results from a phase I study of capecitabine (X), irinotecan (I) and oxaliplatin (O) as first-line therapy in patients (pts) with metastatic colorectal cancer (MCRC)
    Maroun, J.
    Jonker, D.
    Cripps, C.
    Goel, R.
    Lister, D.
    Chiritescu, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [42] Phase I study of capecitabine (C) in combination with cisplatin (DDP) and irinotecan (IRI) in patients (pts) with advanced solid malignancies
    Sayar, H.
    Verschraegen, C. F.
    Smith, H.
    Rabinowitz, I.
    Lee, F. C.
    Shen, Z.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [43] Phase I trial of capecitabine and gemcitabine with radiotherapy in locally advanced pancreatic cancer
    Leong, T.
    Michael, M.
    Price, T.
    Ganju, V
    Strickland, A.
    Jefford, M.
    Muller, A.
    Ngan, S.
    Milner, A.
    Zalcberg, J.
    ANNALS OF ONCOLOGY, 2006, 17 : 34 - 34
  • [44] Intensified neoadjuvant chemoradiotherapy (CRT) with capecitabine and irinotecan in patients with locally advanced rectal cancer (LARC): A phase I/II study.
    Klautke, G
    Foitzik, T
    Ludwig, K
    Klar, EJM
    Fietkau, R
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 292S - 292S
  • [45] Capecitabine (X) and etoposide (E) for patients (PTS) with locally advanced or advanced gastric cancer (AGC): A Mexican oncology study group phase II trial
    Reyes, Salvador
    Tellez, Eduardo
    Fernando, Aldaco
    Julia, Saenz
    Garcia, Antonio
    Fernandez, Raymundo
    Torrecillas, Laura
    Capdeville, Daniel
    Palomo, Alberto
    Delgadilo, Fernando
    ANNALS OF ONCOLOGY, 2006, 17 : 315 - 315
  • [46] Concurrent radiotherapy with capecitabine and weekly irinotecan as neoadjuvant treatment for locally advanced rectal cancer: a phase I/II study
    Klautke, Gunther
    Feyerherd, Peter
    Ludwig, Kaja
    Foitzik, Thomas
    Klar, Ernst
    Fietkau, Rainer
    ANNALS OF ONCOLOGY, 2004, 15 : 80 - 80
  • [47] Phase II study of capecitabine and irinotecan combination chemotherapy in patients with advanced gastric cancer
    Baek, J. H.
    Kim, J. G.
    Jeon, S. B.
    Chae, Y. S.
    Kim, D. H.
    Sohn, S. K.
    Lee, K. B.
    Choi, Y. J.
    Shin, H. J.
    Chung, J. S.
    Cho, G. J.
    Jung, H. Y.
    Yu, W.
    BRITISH JOURNAL OF CANCER, 2006, 94 (10) : 1407 - 1411
  • [48] Phase II study of capecitabine and irinotecan combination chemotherapy in patients with advanced gastric cancer
    J H Baek
    J G Kim
    S B Jeon
    Y S Chae
    D H Kim
    S K Sohn
    K B Lee
    Y J Choi
    H J Shin
    J S Chung
    G J Cho
    H Y Jung
    W Yu
    British Journal of Cancer, 2006, 94 : 1407 - 1411
  • [49] Phase I dose-finding study of capecitabine (X) with escalating irinotecan (I) and oxaliplatin (O) in patients (pts) with previously treated solid tumors.
    Samanta, E
    Rigatos, SK
    Triantafillis, M
    Kourtis, S
    Koutsourakis, G
    Papanikitas, K
    Konstantinopoulou, A
    Koussoulas, V
    Aravantinos, G
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 256S - 256S
  • [50] Capecitabine (X) and Irinotecan (I), in a biweekly schedule, for patients (Pts) with advanced/metastasic colorectal cancer (MCRC): interim analysis of a phase II study
    Garcia-Alfonso, Pilar
    Gonzalez, M. C.
    Gonzalez, E.
    Molina, M.
    Monoz, A.
    Abad, G.
    Garcia, S.
    Lopez, P.
    Belon, J.
    Perez-Manga, G.
    ANNALS OF ONCOLOGY, 2004, 15 : 89 - 89
12345